The success of Sildenafil initially drove a surge for the drug industry, but recent developments present a murky scenario for those considering a stake. Lower-cost competitors are eroding earnings, and ongoing legal https://antonfsfs924435.theobloggers.com/47789520/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-bet